1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6813F094F2F84783565257F1100457D40
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/developing-strong-internal-thought-leader-management-capabilities-inside-medical-affairs
18
19
2018.97.14.91
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25BMR




» Products & Services » » Medical Affairs » Thought Leader Services

Developing Strong Internal Thought Leader Management Capabilities Inside Medical Affairs

ID: POP-267


Features:

19 Info Graphics

37 Data Graphics

400 Metrics

4 Narratives


Pages: 71


Published: Pre-2019


Delivery Format: Shipped


 

License Options:


Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • STUDY SNAPSHOT
  • KEY FINDINGS
  • VIEW TOC AND LIST OF EXHIBITS
In pharma, regulatory and access restrictions have reshaped key interactions with thought leaders. As thought leaders play an integral role in every stage of the product lifecycle, it is critical for the Medical Affairs function to develop robust internal thought leader management capabilities.


Best Practices, LLC undertook this benchmarking study to explore how leading biopharmaceutical companies structure and organize their Medical Affairs function and develop effective relationships with thought leaders. The study also benchmarks the resource levels, internal communication tactics and use of social media for effective thought leader management.
Responses in this study have been presented in regional (US only and global companies) and company size (Large, medium-sized and small companies) segments.


Industries Profiled:
Biopharmaceutical; Biotech; Pharmaceutical; Manufacturing; Consumer Products; Diagnostic; Medical Device; Chemical; Health Care; Clinical Research; Laboratories


Companies Profiled:
Alkermes; Allergan; Baxalta; Bayer; Celldex Therapeutics; CSL Behring; Genentech; Genzyme; GW Pharmaceuticals; Indivior; Jazz Pharmaceuticals; Mesoblast; Neurocrine Biosciences; Norgine; Novo Nordisk; Perrigo Company; Pfizer; ProStrakan; Sanofi; Santen; Shire; Stallergenes; Sunovion; Teva Pharmaceutical Industries Ltd; Theravance; Tris Pharma; UCB Pharma

Study Snapshot

Best Practices, LLC engaged 31 executives from 27 leading biopharmaceutical companies through a benchmarking survey. 7 research participants represented large biopharmaceutical organizations, while the remaining benchmark class emerged from mid-size and small companies. Also 14 companies form a US-only segment, while 13 companies form a Global segment.

Key Findings

· Budget and Functional Responsibilities Should Align: Ideally, companies should align budget management and functional responsibilities to use resources effectively. While Medical Affairs group leads Thought Leader Management in a majority of the companies, the group has less budget decision power than functional responsibility in this area.

· Thought Leader Management Spend is Allocated to Most Important Activities: The importance level of an activity influences the amount of spend for it. For example: Funding Clinical Research Activities has the highest spend and is rated the most important activity by all segments.


Table of Contents

Executive Summary pgs. 3-11
Research Overview pg. 3
Participating Companies & Segmentation pg. 4-5
Key Recommendations pg. 6
Key Findings & Insights pgs. 7-10
Thought Leader Management Leadership and Responsibilities pgs. 11-16
Thought Leader Management Spend and Resource Allocation pgs. 17-22
Importance of Thought Leader Management Activities pgs. 23-27
Managing Thought Leader Interactions pgs. 28-33
Effectiveness of Coordination Methods pgs. 34-40
Social Media Impact on Thought Leader Management pgs. 41-45
Medical Affairs Structure and Leadership pgs. 46-48
Medical Affairs Spend Allocation and Importance of Functions pgs. 49-55
Medical Affairs Spend Ratios pgs. 56-61
Demographics pgs. 62-65
Appendix pg. 66-69

List of Charts & Exhibits

· Leadership for Thought Leader Management
· Functional and Budget Responsibility for Thought Leader management
· Challenges and Success Factors in Developing and Maintaining Strong Thought Leader Management
· Thought Leader Spend as Percent of Total Medical Affairs Spend
· Percentage of the Total Thought Leader Management Spend Allocated to Listed Activities
· Importance of Thought Leader Services to the Success of the Organization
· Tactics to Overcome Access Challenges
· Approaches Employed to Coordinate Thought Leader Management Resources Across Functions to Avoid Redundancy or Confusion
· Increasing the Effective Use of CRM Tools
· Effectiveness of Coordination Methods
· Impact of Social Media on Thought Leader Management Activities
· Effectiveness of Social Media Sources Used with Thought Leaders
· Best Practices for Using Social Media with Thought Leaders
· Challenges in Utilizing Social Media
· Current Medical Affairs Structure
· Challenges and Success Factors in Developing and Maintaining Strong Medical Affairs Capabilities
· Importance and Spend Allocation for Medical Affairs
· Percentage of the Total Medical Affairs Spend Allocated to Different Functions
· Changes Expected in Budget and Full-time Employee (FTE) Resource Levels within the Next 12-24 Months
· Percentage of Medical Affairs Functions' Spending Allocated to Outsourcing Expenses (Vendor Services)
· Importance of Medical Affairs Functions to the Organization
· Issues Affecting Change in Importance of Medical Affairs
· Revenue per Medical Affairs FTE
· Medical Affairs Spend Per In-Market Product
· Medical Affairs Spend Per Pipeline Product
· Medical Affairs Spend per MA FTE